Pharmacology Corner

Articles related to ‘New drugs’

• 

  FDA approves ATryn (recombinant human antithrombin) for the treatment of hereditary antithrombin deficiency

  2/07/09 • (0)

• 

  Rivaroxaban (Xarelto) for the prevention of venous thromboembolism (VTE): SMC review

  1/10/09 • (0)

• 

  Atazanavir (Reyataz) for HIV-1 infection: SMC review

  1/08/09 • (2)

• Nilotinib (Tasigna) for chonic myeloid leukemia: Health Canada evaluation

  1/07/09 • (0)

• Methylnaltrexone (Relistor) for opioid induced constipation: SMC review

  1/07/09 • (2)

• Varenicline (Champix) psychiatric adverse effects: recommendations to patients from Health Canada

  1/06/09 • (0)

• Febuxostat (Adenuric, Ipsen) for the management of hyperuricemia in gout patients. NICE guidance

  1/05/09 • (0)

• Review of nepafenac (Nevanac) ophtalmic suspension

  1/04/09 • (0)

• Etravirine (Intelence) review from Health Canada

  1/03/09 • (1)

• Dabigatran (Pradaxa, Pradax) for the prevention of VTE. Mechanism of action, indications, contraindications, pharmacodynamics and pharmacokinetics.

  1/02/09 • (0)

• Sitaxentan (Thelin) for pulmonary hypertension. Australian Prescriber review

  12/31/08 • (0)

• Degarelix (Firmagon) for prostate cancer: now approved by FDA

  12/31/08 • (0)

• Pramipexole (Sifrol): dopamine agonist for the treatment of Parkinson’s disease

  12/31/08 • (2)

• Duloxetine (Cymbalta, Yentreve): a serotonin-norepinephrine reuptake inhibitor for major depression. Australian prescriber review

  12/25/08 • (0)

© 2010 • Continuing medical education in clinical Pharmacology and Therapeutics | Pharmamotion | Powered by WordPress & Mimbo

Blog Entries • Comments